Worldquant Millennium Advisors LLC Cuts Holdings in Avantor, Inc. (NYSE:AVTR)

Worldquant Millennium Advisors LLC lowered its holdings in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 57.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 415,709 shares of the company's stock after selling 572,358 shares during the period. Worldquant Millennium Advisors LLC owned approximately 0.06% of Avantor worth $8,759,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB grew its stake in Avantor by 99.5% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company's stock worth $26,000 after purchasing an additional 625 shares during the period. Smartleaf Asset Management LLC grew its stake in Avantor by 106.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company's stock worth $34,000 after purchasing an additional 830 shares during the period. Global Retirement Partners LLC grew its stake in Avantor by 76.7% during the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company's stock worth $52,000 after purchasing an additional 1,067 shares during the period. UMB Bank n.a. grew its stake in Avantor by 56.3% during the fourth quarter. UMB Bank n.a. now owns 2,981 shares of the company's stock worth $63,000 after purchasing an additional 1,074 shares during the period. Finally, AlphaQuest LLC acquired a new stake in Avantor during the fourth quarter worth approximately $65,000. Institutional investors and hedge funds own 95.08% of the company's stock.

Analyst Ratings Changes

Several research analysts have issued reports on the company. Royal Bank of Canada cut their price target on Avantor from $24.00 to $20.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. Citigroup cut their price target on Avantor from $22.00 to $18.00 and set a "neutral" rating on the stock in a report on Tuesday, March 4th. Barclays cut their price target on Avantor from $18.00 to $15.00 and set an "overweight" rating on the stock in a report on Monday, April 28th. TD Cowen lowered Avantor from a "buy" rating to a "hold" rating and set a $15.50 price target on the stock. in a report on Monday, April 28th. Finally, The Goldman Sachs Group lowered Avantor from a "buy" rating to a "neutral" rating and cut their price target for the stock from $23.00 to $14.00 in a report on Tuesday, April 29th. Seven investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, Avantor has an average rating of "Hold" and an average target price of $18.88.

Avantor Stock Performance

Avantor stock traded up $0.35 during trading on Tuesday, reaching $13.04. The company had a trading volume of 3,937,968 shares, compared to its average volume of 9,388,124. Avantor, Inc. has a 52 week low of $11.82 and a 52 week high of $28.00. The company has a current ratio of 1.07, a quick ratio of 0.70 and a debt-to-equity ratio of 0.54. The firm has a market capitalization of $8.89 billion, a price-to-earnings ratio of 12.54, a price-to-earnings-growth ratio of 1.55 and a beta of 1.09. The firm's 50-day simple moving average is $14.35 and its 200 day simple moving average is $18.15.

Avantor (NYSE:AVTR - Get Free Report) last issued its quarterly earnings results on Friday, April 25th. The company reported $0.23 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.23. Avantor had a return on equity of 12.17% and a net margin of 10.49%. The business had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.61 billion. During the same quarter in the prior year, the business posted $0.22 EPS. Avantor's revenue for the quarter was down 5.9% compared to the same quarter last year. Sell-side analysts forecast that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Avantor news, Director Gregory L. Summe purchased 25,000 shares of the business's stock in a transaction on Wednesday, May 7th. The stock was acquired at an average price of $12.00 per share, for a total transaction of $300,000.00. Following the purchase, the director now owns 50,000 shares of the company's stock, valued at approximately $600,000. This represents a 100.00% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Joseph R. Massaro purchased 8,100 shares of the business's stock in a transaction on Tuesday, April 29th. The stock was acquired at an average price of $12.30 per share, with a total value of $99,630.00. Following the purchase, the director now directly owns 35,038 shares in the company, valued at $430,967.40. This represents a 30.07% increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders acquired 53,100 shares of company stock worth $652,630. Corporate insiders own 1.20% of the company's stock.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.